General Information of Drug Transporter (DT)
DT ID DTD0505 Transporter Info
Gene Name SLCO6A1
Transporter Name Organic anion-transporting polypeptide 6A1
Gene ID
133482
UniProt ID
Q86UG4
Epigenetic Regulations of This DT (EGR)

Methylation

  Hepatocellular carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in hepatocellular carcinoma [ 1 ]

Location

5'UTR (cg08999764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.29E+00 Statistic Test p-value: 1.46E-14; Z-score: -4.90E+00

Methylation in Case

4.58E-01 (Median) Methylation in Control 5.93E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg26101428)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 2.64E-08; Z-score: -1.60E+00

Methylation in Case

7.33E-01 (Median) Methylation in Control 8.10E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in hepatocellular carcinoma [ 1 ]

Location

Body (cg07318335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.49E+00 Statistic Test p-value: 1.66E-15; Z-score: -2.76E+00

Methylation in Case

5.82E-01 (Median) Methylation in Control 8.67E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in hepatocellular carcinoma [ 1 ]

Location

Body (cg16533977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 7.50E-07; Z-score: -2.50E+00

Methylation in Case

8.99E-01 (Median) Methylation in Control 9.50E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Bladder cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg26101428)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.44E-02; Z-score: -1.48E+00

Methylation in Case

8.87E-01 (Median) Methylation in Control 9.07E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg04589881)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 3.57E-02; Z-score: -1.14E-01

Methylation in Case

8.73E-01 (Median) Methylation in Control 8.74E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

1stExon (cg14719865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.05E-02; Z-score: -1.94E+00

Methylation in Case

7.53E-01 (Median) Methylation in Control 7.82E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

Body (cg08759899)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 8.58E-05; Z-score: -5.50E+00

Methylation in Case

8.56E-01 (Median) Methylation in Control 9.13E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

Body (cg12583394)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.34E-04; Z-score: -4.17E+00

Methylation in Case

8.65E-01 (Median) Methylation in Control 9.15E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLCO6A1 in bladder cancer [ 2 ]

Location

Body (cg16533977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.87E-02; Z-score: -1.07E+00

Methylation in Case

9.60E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in breast cancer [ 3 ]

Location

TSS1500 (cg04589881)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.23E-04; Z-score: -8.15E-01

Methylation in Case

8.44E-01 (Median) Methylation in Control 8.64E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in breast cancer [ 3 ]

Location

TSS1500 (cg26101428)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.04E-02; Z-score: -4.53E-01

Methylation in Case

8.62E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in breast cancer [ 3 ]

Location

1stExon (cg14719865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 8.07E-07; Z-score: -1.38E+00

Methylation in Case

7.44E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in breast cancer [ 3 ]

Location

Body (cg12583394)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.04E-06; Z-score: -1.22E+00

Methylation in Case

8.45E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg04589881)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.29E-04; Z-score: -1.14E+00

Methylation in Case

9.62E-01 (Median) Methylation in Control 9.71E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg26101428)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 4.72E-03; Z-score: -6.70E-01

Methylation in Case

9.63E-01 (Median) Methylation in Control 9.67E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in clear cell renal cell carcinoma [ 4 ]

Location

1stExon (cg14719865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 8.62E-06; Z-score: -1.48E+00

Methylation in Case

8.66E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg16533977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 5.27E-03; Z-score: -5.11E-01

Methylation in Case

9.67E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg20765441)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.31E+00 Statistic Test p-value: 6.57E-06; Z-score: -2.45E+00

Methylation in Case

4.24E-01 (Median) Methylation in Control 5.57E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg25356715)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 3.94E-05; Z-score: -2.34E+00

Methylation in Case

5.61E-01 (Median) Methylation in Control 7.06E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg16548605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 7.55E-04; Z-score: -2.22E+00

Methylation in Case

6.01E-01 (Median) Methylation in Control 7.52E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in colon adenocarcinoma [ 5 ]

Location

Body (cg21743307)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 8.37E-04; Z-score: -9.10E-01

Methylation in Case

3.87E-01 (Median) Methylation in Control 4.41E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in colorectal cancer [ 6 ]

Location

TSS1500 (cg04589881)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 9.03E-06; Z-score: -1.59E+00

Methylation in Case

9.16E-01 (Median) Methylation in Control 9.34E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in colorectal cancer [ 6 ]

Location

TSS200 (cg26192556)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 6.19E-13; Z-score: -3.42E+00

Methylation in Case

6.17E-01 (Median) Methylation in Control 7.61E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in colorectal cancer [ 6 ]

Location

Body (cg12583394)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 9.19E-05; Z-score: -3.26E+00

Methylation in Case

9.32E-01 (Median) Methylation in Control 9.57E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in colorectal cancer [ 6 ]

Location

Body (cg08759899)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.11E-03; Z-score: -8.85E-01

Methylation in Case

9.31E-01 (Median) Methylation in Control 9.40E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg01119072)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 4.47E-06; Z-score: -1.25E+00

Methylation in Case

4.53E-01 (Median) Methylation in Control 5.81E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS1500 (cg15632839)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 1.24E-02; Z-score: -2.38E-01

Methylation in Case

6.88E-02 (Median) Methylation in Control 7.42E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLCO6A1 in pancretic ductal adenocarcinoma [ 7 ]

Location

TSS200 (cg07589968)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 9.64E-14; Z-score: -2.09E+00

Methylation in Case

2.88E-01 (Median) Methylation in Control 3.60E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLCO6A1 in pancretic ductal adenocarcinoma [ 7 ]

Location

3'UTR (cg21477176)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.68E+00 Statistic Test p-value: 3.24E-14; Z-score: 2.79E+00

Methylation in Case

6.12E-01 (Median) Methylation in Control 3.65E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Celiac disease

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in celiac disease [ 8 ]

Location

TSS200 (cg26192556)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 2.85E-02; Z-score: -2.42E-01

Methylation in Case

4.63E-01 (Median) Methylation in Control 5.12E-01 (Median)

Studied Phenotype

Celiac disease [ ICD-11: DA95]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in papillary thyroid cancer [ 9 ]

Location

1stExon (cg14719865)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 4.06E-03; Z-score: -6.68E-01

Methylation in Case

8.50E-01 (Median) Methylation in Control 8.64E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg12583394)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.28E-04; Z-score: -5.93E-01

Methylation in Case

8.84E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in lung adenocarcinoma [ 10 ]

Location

Body (cg16533977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 9.01E-03; Z-score: -1.86E+00

Methylation in Case

9.33E-01 (Median) Methylation in Control 9.48E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLCO6A1 in lung adenocarcinoma [ 10 ]

Location

Body (cg12583394)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.23E-02; Z-score: -2.45E+00

Methylation in Case

8.94E-01 (Median) Methylation in Control 9.24E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLCO6A1 in panic disorder [ 11 ]

Location

Body (cg16533977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 1.48E-02; Z-score: 4.23E-01

Methylation in Case

4.23E+00 (Median) Methylation in Control 4.08E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Liver cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate/moderate hypomethylation of SLCO6A1 in liver cancer than that in healthy individual/adjacent tissue

Studied Phenotype

Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 8.34E-12; Fold-change: -0.237216339; Z-score: -2.732101554

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 6.37E-10; Fold-change: -0.233462491; Z-score: -3.634773266
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
References
1 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
5 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
6 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
7 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
8 The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
9 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
10 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
11 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.